UBE2T and Ewing sarcoma: As a result, based on the above findings, this study demonstrated that UBE2T can be seen as an important value biomarker for diagnosis and treatment of ES, thereby providing a new potential therapeutic target for ES as well as an important new perspective for evaluating the effect of treatment and prognostic prediction.